Press release
COVID-19 Therapeutics Market Outlook 2021: The Strong Pipeline with New Product Approvals to Augment the Market Growth
COVID 19 Therapeutic Antiviral, Monoclonal Antibodies, Anticoagulant, Glucocorticoid, Nitric oxide
For More Information @ https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184
According to the latest market intelligence report by InsightAce Analytic, the global COVID-19 Therapeutics market size was valued at US$ 5.26 Billion in 2019, and it is expected to record a promising CAGR of 10.7% from 2021 to 2030.
The COVID-19 outbreak is caused due to Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), affecting masses of people globally. The coronavirus treatment drugs comprise therapeutics which are used for the treatment of the novel coronavirus. There are numerous drug classes such as corticosteroids, antiviral, monoclonal antibodies, Kinase inhibitors which can be used for the treatment of the coronavirus. In Aug 2021, World Health Organization (WHO) announced Three new candidate drugs are being tested in the latest phase of global Solidarity clinical trials to find effective treatments against COVID-19, including artesunate, imatinib, and infliximab. The market is primarily driven by the increased prevalence of COVID-19 across the globe. The market is further supported by rising awareness about coronavirus and collective efforts by the pharmaceutical companies in the development of covid-19 therapeutic drugs.
Request for ToC/Proposal: https://www.insightaceanalytic.com/request-sample/1184
Some of the key Players of COVID-19 Therapeutics market includes GlaxoSmithKline plc, Fulcrum Therapeutics, CytoDyn, Celltrion, Brii Biosciences Limited, Eli Lilly and Company, Vir Biotechnology, NRX Pharmaceuticals, Shanghai Junshi Biosciences Co., Ltd., Veru Inc., Humanigen, Inc., Catalent, Inc., Cipla Limited, SAb Biotherapeutics, Molecular Partners AG, Merck, Regeneron Pharmaceuticals, Inc., Marinomed Biotech AG, Revive Therapeutics Ltd., Janssen Pharmaceuticals, APEIRON Biologics AG, Bristol Myers Squibb, Novartis International AG,Trevena Inc, Ono Pharmaceutical Co., Ltd., Constant Therapeutics LLC, Amarin Corporation plc, FUJIFILM Toyama Chemical Co., Ltd., NeuroBo Pharmaceuticals, Inc., Innovation Pharmaceuticals Inc., Bellerophon Therapeutics, PhaseBio, Sorrento Therapeutics, Pfizer, Celltex Therapeutics, Takeda, BioAegis Therapeutics, Roivant Sciences, A.I. Therapeutics, Inc., Blade Therapeutics, Synairgen, Atea Pharmaceuticals, Inc., Romark Laboratories, L.C., Kiniksa Pharmaceuticals, UNION therapeutics A/S, and Other Prominent Players.
Key Developments:
• In Aug 2021, CytoDyn Receives Clearance from Brazil's ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients. In May 2021, CytoDyn and academic research organization (ARO) Albert Einstein Israelite Hospital (AEIH) agreed to commence two Phase III trials of HIV drug leronlimab (Vyrologix or PRO 140) in patients with severe Covid-19
• In Aug 2021, Lupin, Glenmark focusing on coming up with re-purposed inhalation products for Covid-19. Lupin is working on a remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission
• In June 2021, NRx Pharmaceuticals has applied for the US FDA's EUA approval for Zyesami, which showed positive signs for Covid-19 therapy according to trial data.Zyesami is the first reported therapy to show better recovery and survival in Covid-19 patients with respiratory failure
• In June 2021, Atea Pharmaceuticals has announced positive interim results from its global Phase II study that examines the role of AT-527, an oral antiviral drug, in the treatment of hospitalised Covid-19 patients suffering from mild-to-moderate symptoms. Roche and Atea are jointly developing the oral direct-acting antiviral agent derived from Atea's purine nucleotide prodrug platform
Request for ToC/Proposal: https://www.insightaceanalytic.com/request-sample/1184
Geographically, North America holds a significant revenue share in terms of R&D in the global covid-19 therapeutics market due to raised government spending on the development of drugs, growing government initiatives for R&D of covid-19 vaccines, and an increasing number of market players. The Asia Pacific region is expected to witness faster growth in the target market due to increasing efforts by the government to enhance the drug production and increasing number of research and development activities. In Jun 2021, Eli Lilly and Company India has received a nod from India's drug regulator for emergency use of its antibody drugs combination, which is used for the treatment of mild to moderate COVID-19 patients. Company has received approval for monoclonal antibody drugs, bamlanivimab 700 mg and etesevimab 1400 mg. Both of these drugs are used together for the treatment of patients with mild to moderate COVID-19.
The Global COVID-19 therapeutic Market Segments
The Global COVID-19 therapeutic Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Drug Class
• Monoclonal Antibodies
• Antiviral
• Anticoagulant
• Glucocorticoid
• Nitric oxide
• Other Drug Class
The Global COVID-19 therapeutic Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Infection Type
• HCoV-229E
• HCoV-OC43
• SARS-CoV
• New Haven CoV
• HKU1-CoV
• MERS-CoV
• Other Infection Types
The Global COVID-19 therapeutic Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2030 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America COVID-19 Therapeutics market revenue (US$ Million) by Country, 2019 to 2030
• U.S.
• Canada
Europe COVID-19 Therapeutics market revenue (US$ Million) by Country, 2019 to 2030
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific COVID-19 Therapeutics market revenue (US$ Million) by Country, 2019 to 2030
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America COVID-19 Therapeutics market revenue (US$ Million) by Country, 2019 to 2030
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa COVID-19 Therapeutics market revenue (US$ Million) by Country, 2019 to 2030
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
- To receive a comprehensive analysis of the prospects for global COVID-19 Therapeutics market
- To analyze the COVID-19 Therapeutics clinical trial/pipeline analysis
- To receive industry overview and future trends of COVID-19 Therapeutics market
- To analyze the COVID-19 Therapeutics market drivers and challenges
- To get information on COVID-19 Therapeutics market size value (US$ Mn) forecast till 2030
- Major Investments, Mergers & Acquisition in COVID-19 Therapeutics market industry
For More Information @ https://www.insightaceanalytic.com/report/global-covid-19-therapeutics-market/1184
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COVID-19 Therapeutics Market Outlook 2021: The Strong Pipeline with New Product Approvals to Augment the Market Growth here
News-ID: 2384941 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for COVID
COVID-19 Diagnostics Market Analysis and Forecast to 2033: COVID-19 and Post-COV …
The COVID-19 diagnostics market is projected to reach a size of US$ 79.41 billion in 2023, with a robust compound annual growth rate (CAGR) of 7.87% from 2023 to 2033. This growth is primarily driven by technological advancements in diagnostic tools and methodologies, enabling faster and more accurate detection of the virus. However, the market faces several challenges, including the perception of high costs, along with concerns regarding test accuracy…
COVID-19 Molecular Diagnostics Market Insights by 2027 & Covid-19 Analysis | BD, …
This detailed assessment COVID-19 Molecular Diagnostics market report highlights data about various aspects, which includes growth factors and restraints. Crucial information about market scenario provided in this market report greatly helps key stakeholder in making right decision before making an investment in the market. This report further provides an overview on well-known industries, their market contribution, successful market strategies and latest advancements in present contexts. It also covers market analysis…
Europe COVID-19 Diagnostic Market Size | COVID-19 Impact Analysis | Forecast to …
Europe COVID-19 Diagnostic market is estimated to reach $2.6 billion in 2027, by growing at a CAGR of -22.9 % during the forecast period (2021-2027). Several projects for the development of COVID-19, diagnosis, and treatment were reported over the last few months. Additionally, on 22 July 2020, the European Commission declared nearly $117.8 million to co-fund a call for supporting R&D of coronavirus vaccines, and to develop diagnostic tests, treatments,…
Anti-Covid nasal spray Market (Covid-19 Impact)| Game Changer For Globe | SaNOti …
Global Anti-Covid nasal spray Market Size, Status and Forecast 2026
Israel and New Zealand have given interim approval for the sale of biotech firm SaNOtize Research and Development’s Nitric Oxide Nasal Spray (NONS) which could help prevent transmission of the COVID-19 virus, the company said on Monday. (Reuters)
A self-administered nitric oxide nasal spray (NONS) made by Vancouver-based biotech firm SaNOtize has been found to dramatically reduce Covid-19 viral load in infected…
COVID-19 Imparts Positive Impact on Covid-19 Treatment Market | 2020-2027
The Covid-19 treatment market is projected to grow due to increasing cases worldwide requiring short- and long-term respiratory support and multiple partnerships for the development of treatments with clinical trials underway. However, governments all over the world are now responding to the threat of COVID-19 with all the essential measures such as social distancing, nationwide lockdown, travel restrictions, and large-scale quarantines that are anticipated to impact the businesses and consumer…
Industrial AI Computers Market 2020 - Pre-COVID-19 and Post-COVID-19 Comparison
Industrial AI Computers Industry 2020 Market Research Report" A new report added by DeepResearchReports.com to its research database. Industrial AI Computers Market is segmented by Regions/Countries. All the key market aspects that influence the Industrial AI Computers market currently and will have an impact on it have been assessed and propounded in the Industrial AI Computers market research status and development trends reviewed in the new report.
Download Free PDF Sample…
